We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

Back to rankings

158 hedge funds and large institutions have $2.19B invested in AUXILIUM PHARAMCEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 37 increasing their positions, 53 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $86.6M | Put options by funds: $38.9M

25% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 40

11% more capital invested

Capital invested by funds: $1.97B → $2.19B (+$221M)

5% more funds holding

Funds holding: 150 → 158 (+8)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

30% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 53

Holders
158
Holders Change
+8
Holders Change %
+5.33%
% of All Funds
4.21%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.21%
New
50
Increased
37
Reduced
53
Closed
40
Calls
$86.6M
Puts
$38.9M
Net Calls
+$47.6M
Net Calls Change
-$40.2M

Top Buyers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
+$121M
2
FCM
Farallon Capital Management
California
+$80.1M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$79M
4
OAM
Oxford Asset Management
United Kingdom
+$68.6M
5
MP
Manikay Partners
New York
+$62M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$190M
2
PC
Paulson & Co
New York
-$119M
3
JCI
Jet Capital Investors
New York
-$62.7M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$62.1M
5
CCM
Consonance Capital Management
New York
-$44.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
POA
126
Pergamon Offshore Advisors
New York
$366K +$347K +10,638 New
KBC Group
127
KBC Group
Belgium
$356K +$337K +10,348 New
NFC
128
Northeast Financial Consultants
Connecticut
$344K – – –
TCM
129
TimesSquare Capital Management
New York
$323K -$39.6M -1,213,195 -99%
Principal Financial Group
130
Principal Financial Group
Iowa
$322K -$32.8K -1,007 -10%
PRC
131
Platte River Capital
Colorado
$292K +$277K +8,500 New
Legal & General Group
132
Legal & General Group
United Kingdom
$262K -$7.7K -236 -3%
Marshall Wace
133
Marshall Wace
United Kingdom
$259K +$246K +7,534 New
TRCT
134
Tower Research Capital (TRC)
New York
$240K +$211K +6,476 +1,260%
AG
135
Aperio Group
California
$218K +$207K +6,333 New
RFC
136
Russell Frank Company
Washington
$200K – – –
PAM
137
Panagora Asset Management
Massachusetts
$196K -$164K -5,039 -47%
OAM
138
Orinda Asset Management
California
$172K +$163K +5,000 New
Royal Bank of Canada
139
Royal Bank of Canada
Ontario, Canada
$155K -$222K -6,796 -60%
Canada Life
140
Canada Life
Manitoba, Canada
$146K – – –
Wells Fargo
141
Wells Fargo
California
$97K +$294 +9 +0.3%
FMT
142
First Mercantile Trust
Tennessee
$68K -$64.2K -1,970 -50%
Creative Planning
143
Creative Planning
Kansas
$58K – – –
BlackRock
144
BlackRock
New York
$51K – – –
Teacher Retirement System of Texas
145
Teacher Retirement System of Texas
Texas
$50K -$8.35K -256 -15%
Northwestern Mutual Wealth Management
146
Northwestern Mutual Wealth Management
Wisconsin
$50K – – –
US Bancorp
147
US Bancorp
Minnesota
$48K +$391 +12 +0.9%
BJ
148
BlackRock Japan
Japan
$42K -$16.1K -494 -29%
FAM
149
Fred Alger Management
New York
$13K – – –
M
150
MOTCO
Texas
$7K -$15.2K -466 -69%
4 5
6
7 8

AUXL Hedge Fund Activity: Q4 2014 in Review

158 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q4 2014, worth a combined $2.19B — up 11% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new AUXL positions and 40 closed out — a net gain of 10 holders — while 37 added to existing stakes and 53 trimmed.

The largest buyer was Pentwater Capital Management, adding an estimated $121M. The largest seller was Fidelity Investments, exiting entirely with an estimated $190M sold.

  • 158 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q4 2014, up from 150 in Q3 2014.
  • Funds reported $2.19B of AUXILIUM PHARAMCEUTICALS INC stock for Q4 2014, up 11% quarter-over-quarter.
  • 50 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q4 2014 and 40 closed out, a net change of +10 holders.
  • The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q4 2014 was Pentwater Capital Management, an estimated $121M added.
  • The largest AUXILIUM PHARAMCEUTICALS INC seller in Q4 2014 was Fidelity Investments, an estimated $190M sold.

Based on aggregated 13F filings for Q4 2014.